ES8203226A1 - Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. - Google Patents

Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.

Info

Publication number
ES8203226A1
ES8203226A1 ES500567A ES500567A ES8203226A1 ES 8203226 A1 ES8203226 A1 ES 8203226A1 ES 500567 A ES500567 A ES 500567A ES 500567 A ES500567 A ES 500567A ES 8203226 A1 ES8203226 A1 ES 8203226A1
Authority
ES
Spain
Prior art keywords
specific antigen
vaccinal
vaccine
complex
complex containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES500567A
Other languages
English (en)
Other versions
ES500567A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of ES8203226A1 publication Critical patent/ES8203226A1/es
Publication of ES500567A0 publication Critical patent/ES500567A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENO PARA LA OBTENCION DE COMPLEJOS VACUNANTES POR REACCION DE ARN RIBOSOMALES Y DE ANTIGENOS ESPECIFICOS. CONSISTE EN EL ACOPLAMIENTO POR VIA QUIMICA, MEDIANTE ENLACES COVALENTES, A UNOS ARN RIBOSOMALES BACTERIANOS O FRAGMENTOS DE LOS MISMOS, QUE SE PUEDEN EXTRAER DE LOS RIBOSOMAS DE DIVERSOS TIPOS DE ESPECIAS BACTERIANAS, DE 1 A POR 100 DE UN ANTIGENO ESPECIFICO DE SEROTIPO BACTERIANO, ELEGIDO ENTRE POLISACARIDOS, LIPOPOLISACARIDOS, PROTEINAS Y ACIDOS TEICOICOS Y LIPOTEICOICOS. ESTOS COMPLEJOS TIENEN APLICACIONES FARMACOLOGICAS POR SU EFECTO INMUNOGENICO.
ES500567A 1980-02-20 1981-02-20 Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. Granted ES500567A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8003707A FR2475900A1 (fr) 1980-02-20 1980-02-20 Complexe vaccinal contenant un antigene specifique et vaccin le contenant

Publications (2)

Publication Number Publication Date
ES8203226A1 true ES8203226A1 (es) 1982-04-16
ES500567A0 ES500567A0 (es) 1982-04-16

Family

ID=9238765

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500567A Granted ES500567A0 (es) 1980-02-20 1981-02-20 Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.

Country Status (10)

Country Link
US (1) US4460575A (es)
EP (1) EP0035429B1 (es)
JP (1) JPS56131523A (es)
AT (1) ATE13741T1 (es)
AU (1) AU543201B2 (es)
CA (1) CA1181691A (es)
DE (1) DE3170913D1 (es)
ES (1) ES500567A0 (es)
FR (1) FR2475900A1 (es)
ZA (1) ZA811125B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870053A (en) * 1980-09-19 1989-09-26 Roussel Uclaf Novel compositions and processes
US5641631A (en) * 1983-01-10 1997-06-24 Gen-Probe Incorporated Method for detecting, identifying, and quantitating organisms and viruses
US4650675A (en) * 1983-08-18 1987-03-17 The Children's Medical Center Corporation Oligonucleotide conjugates
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
US5346999A (en) * 1985-01-18 1994-09-13 Applied Biosystems, Inc. Method of nucleic acid extraction
US4689222A (en) * 1985-01-18 1987-08-25 Mcmichael John Methods and materials for alleviation of pain symptoms of malignant neoplasia
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US4873090A (en) * 1985-03-27 1989-10-10 Broncostat Pty. Limited Non-adjuvenated vaccine
WO1986006279A1 (en) * 1985-04-30 1986-11-06 Scripps Clinic And Research Foundation Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
US4701323A (en) * 1985-10-23 1987-10-20 Iowa State University Research Foundation, Inc. Vaccines for counteracting inhibition of neutrophil degranulation
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
CA2049548C (en) * 1990-08-20 2002-07-02 Kiyoshi Yoshimura Lps-producing bacteria, lpss, and lps-containing medicines and veterinary medicines
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
JPH09163896A (ja) * 1995-12-13 1997-06-24 Sumitomo Pharmaceut Co Ltd 胸膜炎病態モデル動物
FR2745186B1 (fr) * 1996-02-26 1998-12-31 Torossian Fernand Narbey Complexe immunomodulateur et ses utilisations pour le traitement et la prevention des recidives des affections par helicobacter
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
GB2325233B (en) * 1997-05-16 2001-07-18 Norsk Hydro As Substrates having bound polysaccharides and bacterial nucleic acids
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
ATE498409T1 (de) 1998-08-06 2011-03-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
WO2002045742A2 (en) * 2000-09-12 2002-06-13 U.S. Army Medical Research And Materiel Command Lipoteichoic acid immunogenic compositions and methods of making and using thereof
GB2370839A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex useful for disease control
GB2370838A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
WO2003060143A2 (en) * 2001-10-26 2003-07-24 Id Biomedical Corporation Of Washington Efficient protein expression system
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
HU229626B1 (hu) * 2005-04-11 2014-03-28 Savient Pharmaceuticals Urát oxidáz változat és alkalmazása
CA2604399A1 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
US9534013B2 (en) 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
US9377454B2 (en) 2009-06-25 2016-06-28 Crealta Pharmaceuticals Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725545A (en) * 1971-02-03 1973-04-03 R Maes Enhancement of antibody production by nucleic acid-polycation complexes
FR2253499B1 (es) * 1973-12-10 1977-11-04 Fabre Sa Pierre
US3952097A (en) * 1974-09-27 1976-04-20 The United States Of America As Represented By The Department Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
FR2305990A1 (fr) * 1975-04-02 1976-10-29 Fabre Sa Pierre Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens
FR2360314A2 (fr) * 1976-08-06 1978-03-03 Fabre Sa Pierre Nouveaux vaccins perfectionnes a base de fractions ribosomales
FR2374911A1 (fr) * 1976-12-21 1978-07-21 Fabre Sa Pierre Adjuvants d'immunite non specifique
FR2388563A1 (fr) * 1977-04-29 1978-11-24 Fabre Sa Pierre Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
US4285930A (en) * 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy

Also Published As

Publication number Publication date
ZA811125B (en) 1982-03-31
FR2475900A1 (fr) 1981-08-21
US4460575A (en) 1984-07-17
AU6750181A (en) 1981-08-27
EP0035429A1 (fr) 1981-09-09
FR2475900B1 (es) 1983-06-10
EP0035429B1 (fr) 1985-06-12
JPS56131523A (en) 1981-10-15
AU543201B2 (en) 1985-04-04
ES500567A0 (es) 1982-04-16
ATE13741T1 (de) 1985-06-15
DE3170913D1 (en) 1985-07-18
CA1181691A (en) 1985-01-29

Similar Documents

Publication Publication Date Title
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
PH20502A (en) Quarternary 6,11-dihydro-dibenzo-(b,e)-thiepine-11-n-alkyl-norscopine ethers
EP0121249A3 (en) Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
HK37397A (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
IL65835A (en) Protozoal antigen,its preparation and vaccine containing it
ES498476A0 (es) Procedimiento de preparacion de arn ribosomales bacterianos
IL59663A0 (en) Vaccines obtained from bacterial mutant strains
GB2031433B (en) Modification of the quercitin moiety of timothy grass pollen antigens or fragments thereof
IL65496A (en) Protozoal antigen,its preparation and vaccine containing it
AR229760A1 (es) Composicion agricola conteniendo un microorganismo que lleva un plasmido hr no patogeno para la zanahoria,e inoculante para aumentar la nodulacion y la masa de raices y tallos en una leguminosa conteniendo dicha composicion
PT73740A (en) Novel benzoxazolinones substituted in the 6-position by an amino-alcohol chain or amino-ketone chain their preparation and their use in pharmaceutical preparations
IL95639A (en) Regulatory dna sequence
IL70069A0 (en) Novel strains of azospirillum,methods of growing the strains,compositions containing them and use thereof as biofertilizer
DE2961090D1 (en) Processing of foodstuffs and composition for the protection of microorganisms used in foodstuff-processing
ES8303522A1 (es) Procedimiento para la mutacion doble de virus del genero herpes
DE3068224D1 (en) Vaccines from taxonomically similar organisms
DE3270747D1 (en) Oil, its preparation and its use, particularly in cosmetics
DE3071500D1 (en) Water-soluble extract from nonpathogenic aerobic corynebacteria, production thereof and compositions containing the extract
DE69429521T2 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
PH14329A (en) Anti-depressant carbazoles,their pharmaceutical compositions and method of use
GR73033B (es)
IL58677A0 (en) Process for the preparation of 1 ,3 -dihydroxy- -steroids and intermediates useful in the process
JPS54147923A (en) Novel composition and method
EP0300741A3 (en) Human thymopoietin
IT1129633B (it) Procedimento per il trattamento anticorrosivo di prodotti in acciaio

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010219